Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Th17 cells in Type 1 diabetes: a future perspective.

Literature DB >> 27708719

Th17 cells in Type 1 diabetes: a future perspective.

Laura A Solt¹, Thomas P Burris².

Abstract

Entities: Chemical Disease Gene Species

Keywords: IL17; Th17 cell; autoimmunity; drug discovery; nuclear receptor; orphan receptor

Year: 2015 PMID： 27708719 PMCID： PMC5046833 DOI： 10.2217/DMT.15.19

Source DB: PubMed Journal: Diabetes Manag (Lond) ISSN： 1758-1907

× No keyword cloud information.

19 in total

1. ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes.

Authors: Laura A Solt; Subhashis Banerjee; Sean Campbell; Theodore M Kamenecka; Thomas P Burris
Journal: Endocrinology Date: 2015-01-05 Impact factor: 4.736

Review 2. Th17 cells in type 1 diabetes.

Authors: Shiying Shao; Fan He; Yan Yang; Gang Yuan; Muxun Zhang; Xuefeng Yu
Journal: Cell Immunol Date: 2012-11-28 Impact factor: 4.868

Review 3. The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARγ, RORs, and Rev-erbs.

Authors: David P Marciano; Mi Ra Chang; Cesar A Corzo; Devrishi Goswami; Vinh Q Lam; Bruce D Pascal; Patrick R Griffin
Journal: Cell Metab Date: 2014-01-16 Impact factor: 27.287

4. IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes.

Authors: Julie Joseph; Stefan Bittner; Fabian M P Kaiser; Heinz Wiendl; Stephan Kissler
Journal: J Immunol Date: 2011-11-23 Impact factor: 5.422

Review 5. CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes.

Authors: Kathryn Haskins; Anne Cooke
Journal: Curr Opin Immunol Date: 2011-09-12 Impact factor: 7.486

6. Th1/Th17 plasticity is a marker of advanced β cell autoimmunity and impaired glucose tolerance in humans.

Authors: Linnea Reinert-Hartwall; Jarno Honkanen; Harri M Salo; Janne K Nieminen; Kristiina Luopajärvi; Taina Härkönen; Riitta Veijola; Olli Simell; Jorma Ilonen; Aleksandr Peet; Vallo Tillmann; Mikael Knip; Outi Vaarala
Journal: J Immunol Date: 2014-12-05 Impact factor: 5.422

7. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.

Authors: David Bending; Hugo De la Peña; Marc Veldhoen; Jenny M Phillips; Catherine Uyttenhove; Brigitta Stockinger; Anne Cooke
Journal: J Clin Invest Date: 2009-02-02 Impact factor: 14.808

8. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.

Authors: Laura A Solt; Naresh Kumar; Philippe Nuhant; Yongjun Wang; Janelle L Lauer; Jin Liu; Monica A Istrate; Theodore M Kamenecka; William R Roush; Dušica Vidović; Stephan C Schürer; Jihong Xu; Gail Wagoner; Paul D Drew; Patrick R Griffin; Thomas P Burris
Journal: Nature Date: 2011-04-17 Impact factor: 49.962

9. TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?

Authors: Ashish K Marwaha; Nicole J Leung; Alicia N McMurchy; Megan K Levings
Journal: Front Immunol Date: 2012-06-04 Impact factor: 7.561

10. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

Authors: Juliet A Emamaullee; Joy Davis; Shaheed Merani; Christian Toso; John F Elliott; Aducio Thiesen; A M James Shapiro
Journal: Diabetes Date: 2009-03-16 Impact factor: 9.461

8 in total

Review 1. IL-17 and limits of success.

Authors: Zahra Omidian; Rizwan Ahmed; Adebola Giwa; Thomas Donner; Abdel Rahim A Hamad
Journal: Cell Immunol Date: 2018-09-17 Impact factor: 4.868

Review 2. Relevance of Essential Trace Elements in Nutrition and Drinking Water for Human Health and Autoimmune Disease Risk.

Authors: Daniela Cannas; Eleonora Loi; Matteo Serra; Davide Firinu; Paolo Valera; Patrizia Zavattari
Journal: Nutrients Date: 2020-07-13 Impact factor: 5.717

Th17 cells in Type 1 diabetes: a future perspective.

1. ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes.

Review 2. Th17 cells in type 1 diabetes.

Review 3. The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARγ, RORs, and Rev-erbs.

4. IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes.

Review 5. CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes.

6. Th1/Th17 plasticity is a marker of advanced β cell autoimmunity and impaired glucose tolerance in humans.

7. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.

8. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.

9. TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?

10. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

Review 1. IL-17 and limits of success.

Review 2. Relevance of Essential Trace Elements in Nutrition and Drinking Water for Human Health and Autoimmune Disease Risk.

Review 3. Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes.

Review 4. Mast Cells as Important Regulators in Autoimmunity and Cancer Development.

Review 5. Th17 cells and inflammation in neurological disorders: Possible mechanisms of action.

6. Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children.

Review 7. Insight Into Non-Pathogenic Th17 Cells in Autoimmune Diseases.

Review 8. Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy.